Humacyte Inc. (HUMA)
NASDAQ: HUMA
· Real-Time Price · USD
2.61
-0.06 (-2.25%)
At close: Jun 02, 2025, 3:59 PM
2.67
2.29%
After-hours: Jun 02, 2025, 07:56 PM EDT
-2.25% (1D)
Bid | 2.59 |
Market Cap | 404.86M |
Revenue (ttm) | 7.75M |
Net Income (ttm) | -77.67M |
EPS (ttm) | -0.69 |
PE Ratio (ttm) | -3.78 |
Forward PE | -9.88 |
Analyst | Buy |
Ask | 2.67 |
Volume | 4,247,873 |
Avg. Volume (20D) | 4,605,249 |
Open | 2.71 |
Previous Close | 2.67 |
Day's Range | 2.56 - 2.82 |
52-Week Range | 1.15 - 9.79 |
Beta | 1.64 |
About HUMA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol HUMA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for HUMA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+31.06%
Humacyte shares are trading higher after the compa...
Unlock content with
Pro Subscription
2 months ago
-30.56%
Humacyte shares are trading lower after the company priced a $50 million public offering of 25 million common shares at $2.00 per share.

2 months ago · seekingalpha.com
Humacyte, Inc. (HUMA) Q4 2024 Earnings Conference Call TranscriptHumacyte, Inc. (NASDAQ:HUMA ) Q4 2024 Earnings Conference Call March 27, 2025 8:30 AM ET Company Participants Thomas Johnson - Director, Corporate Communications, LifeSci Advisors, IR Laura Niklason -...